NY-ESO-1ᶜ²⁵⁹T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NY-ESO-1ᶜ²⁵⁹T, covering 2020-07-09 to 2020-07-09. Get the full timeline:
Most recent: Clinical Trial Update: A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma [Phase 1]